Literature DB >> 16303349

Cleaning efficacy of single-purpose surfactant cleaners and multi-purpose solutions.

V J Franklin1.   

Abstract

The initial stages of contact lens spoilation are rapid with respect to the deposition of tear components, in particular, lipids and proteins. In addition, extrinsic factors such as care solutions, cosmetics, skin lipids, drugs and tobacco smoke may all play an important part in the spoilation process. Care systems have different effects on this spoilation. Assessment of the relative cleaning efficacies of the single purpose and multipurpose cleaners which are now available in the UK (e.g. ReNu, Optifree, Complete), is of importance in understanding progressive contact lens-tear interactions. This paper furthers our understanding of the efficacies of these solutions in removing the deposition of tear components from the contact lens.

Entities:  

Year:  1997        PMID: 16303349     DOI: 10.1016/s1367-0484(97)80042-2

Source DB:  PubMed          Journal:  Cont Lens Anterior Eye        ISSN: 1367-0484            Impact factor:   3.077


  4 in total

1.  Activity of Deposited Lysozyme on Contemporary Soft Contact Lenses Exposed to Differing Lens Care Systems.

Authors:  Miriam Heynen; Alan Ng; Elizabeth Martell; Lakshman N Subbaraman; Lyndon Jones
Journal:  Clin Ophthalmol       Date:  2021-04-23

2.  Deposit buildup on prosthetic eye material (in vitro) and its effect on surface wettability.

Authors:  Keith Raymond Pine; Brian Sloan; Kyuyeon Ivy Han; Simon Swift; Robert John Jacobs
Journal:  Clin Ophthalmol       Date:  2013-02-13

3.  The efficiency of contact lens care regimens on protein removal from hydrogel and silicone hydrogel lenses.

Authors:  Doerte Luensmann; Miriam Heynen; Lina Liu; Heather Sheardown; Lyndon Jones
Journal:  Mol Vis       Date:  2010-01-20       Impact factor: 2.367

4.  Deposit buildup on prosthetic eyes and implications for conjunctival inflammation and mucoid discharge.

Authors:  Keith Raymond Pine; Brian Sloan; Robert John Jacobs
Journal:  Clin Ophthalmol       Date:  2012-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.